Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

38.66
-1.0000-2.52%
Post-market: 39.000.3400+0.88%19:55 EDT
Volume:4.64M
Turnover:182.75M
Market Cap:4.30B
PE:-27.02
High:41.14
Open:39.80
Low:38.35
Close:39.66
52wk High:41.14
52wk Low:8.46
Shares:111.19M
Float Shares:82.57M
Volume Ratio:0.53
T/O Rate:5.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:17.97
PE(LYR):-25.26

Loading ...

Aug 20, 2026

Major Issues Report

Form 8-K - Current report
Aug 18, 2026

Major Issues Report

Form 8-K - Current report
Aug 18, 2026

Major Issues Report

Form 8-K - Current report
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
Mar 24, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities